Company Profiles

driven by the PitchBook Platform

AccuraGen

AccuraGen
2013 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Series B LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
$46.9M TOTAL AMOUNT RAISED
Description

Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's liquid biopsy technology circulates DNA from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer-mutation detection services.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
1445 Adams Drive
Suite 1015
Menlo Park, CA 94025
United States

+1 (650) 618-5028
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AccuraGen’s full profile, request a free trial.

AccuraGen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 02-Jun-2016 $40M $46.9M Completed Startup
2. Early Stage VC (Series A) 06-Feb-2015 00.00 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

AccuraGen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0
DT Capital Partners PE/Buyout Minority 000 0000 000000 0
Decheng Capital Venture Capital Minority 000 0000 000000 0
Denlux Capital Other Minority 000 0000 000000 0
Junson Capital Family Office Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

AccuraGen Executive Team (7)

Name Title Board
Seat
Contact
Info
Kang Ying Ph.D Co-Founder, Chief Executive Officer and Chairman
Shengrong Lin Ph.D Co-Founder, President, Chief Technology Officer and Board Member
Grace Zhao Ph.D Co-Founder and Director of Research
Zhaohui Sun Co-Founder & CIO
Paul Tang Ph.D Co-Founder & Vice President of Business Development & Product
You’re viewing 5 of 7 executives. Get the full list »

AccuraGen Board Members (4)

Name Representing Role Since Contact
Info
Dan Zabrowski Ph.D Decheng Capital Board Member 000 0000
Kevin Liu Junson Capital Board Member 000 0000
Min Cui Ph.D Decheng Capital Board Member 000 0000
Wei Xu Denlux Capital Board Member 000 0000

You’re viewing 4 of 4 board members.